11/26/2020, 5:55 PM (Source: TeleTrader)
more TeleTrader news

AstraZeneca to conduct additional global vaccine trials - CEO

AstraZeneca Plc. CEO Pascal Soriot unveiled on Thursday that the company aims to conduct another coronavirus vaccine trial globally.

However, it's unlikely for the vaccine's approval process to be delayed in the United Kingdom and the European Union due to the additional testing, he said, adding the approval may take more time in the United States as the US Food and Drug Administration is not expected to take trials conducted outside the country into account.

"Now that we've found what looks like a better efficacy we have to validate this, so we need to do an additional study," he said. According to Soriot, this trial "could be faster because we know the efficacy is high so we need a smaller number of patients."

Breaking the News / GA